Quick Takeaways
- Schonfeld Strategic Advisors LLC filed SCHEDULE 13G/A for Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT).
- Disclosed ownership: 3.3%.
- Date of event: 31 Mar 2025.
Schonfeld Strategic Advisors LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)
- Filing Manager
- Schonfeld Strategic Advisors LLC
- Reporting Manager
- Schonfeld Strategic Advisors LLC
- Symbol
- APLT
- Shares outstanding
- 141,699,909 shares
- Disclosed Ownership
- 4,676,097 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:30:28 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Schonfeld Strategic Advisors LLC disclosed 3.3% ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 15 May 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 3.3% | 4,676,097 | 4,676,097 | 0 | /s/ Hung Luc | Hung Luc, Chief Compliance Officer |